These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8232765)

  • 21. [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].
    Makarenko EIu; Andreeva LA; Borovik AS; Mart'ianov AA
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):71-9. PubMed ID: 15773582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT; Lee G; Vale W; Rivier J; Koob GF
    Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats.
    Eutamene H; Theodorou V; Fioramonti J; Bueno L
    J Physiol; 2003 Dec; 553(Pt 3):959-66. PubMed ID: 14555722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function.
    Brown MR; Gray TS; Fisher LA
    Regul Pept; 1986 Dec; 16(3-4):321-9. PubMed ID: 3031745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
    Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
    J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
    Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential relationship between actions of CRF and PGE2 in the brain on splenic sympathetic nerve activity in rats.
    Katafuchi T; Ichijo T; Hori T
    J Auton Nerv Syst; 1997 Dec; 67(3):200-6. PubMed ID: 9479672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin-releasing factor and schedule-induced polydipsia.
    Cole BJ; Koob GF
    Pharmacol Biochem Behav; 1994 Mar; 47(3):393-8. PubMed ID: 8208756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
    Conti LH; Costello DG; Martin LA; White MF; Abreu ME
    Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.
    Tucci S; Cheeta S; Seth P; File SE
    Psychopharmacology (Berl); 2003 May; 167(3):251-6. PubMed ID: 12669178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
    J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.
    Heinrichs SC; Menzaghi F; Pich EM; Baldwin HA; Rassnick S; Britton KT; Koob GF
    Neuropsychopharmacology; 1994 Nov; 11(3):179-86. PubMed ID: 7865099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
    Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
    J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
    De Boer SF; Katz JL; Valentino RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):335-42. PubMed ID: 1625207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats.
    Morimoto A; Nakamori T; Morimoto K; Tan N; Murakami N
    J Physiol; 1993 Jan; 460():221-9. PubMed ID: 8487193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.
    Vergoni AV; Bertolini A; Wikberg JE; Schiöth HB
    Peptides; 1999; 20(4):509-13. PubMed ID: 10458522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.